Literature DB >> 27113026

miRNA-29b improves bone healing in mouse fracture model.

Wayne Y Lee1, Nan Li2, Sien Lin3, Bin Wang3, Hui Y Lan4, Gang Li3.   

Abstract

A number of miRNAs regulates bone remodeling and their levels in circulation were associated with bone fracture, however no miRNAs have yet been shown to improve fracture healing directly. This study aimed to investigate the effect of miR-29b-3p on mice femoral fracture healing through site-specific delivery with microbubble-ultrasound system. miR-29b-3p promoted osteogenesis of mouse bone marrow-derived mesenchymal stem cells as indicated with quantitative real-time polymerase chain reaction (qPCR) and Alizarin red S staining. Animal study showed that single injection of miR-29b-3p at week 2 post fracture improved healing outcome as indicated by significant decrease of callus width and area with radiographic analysis without causing significant weight loss. Static bone histomorphometry analysis showed that miR-29b-3p increased bone volume fraction (BV/TV), and micro-computed tomography (micro-CT) measurement showed increased BV/TV of high density bone and bone mineral density (BMD) of the callus. 3 point bending mechanical test showed improved relative stiffness. However, repeated injection of miR-29b-3p at weeks 2 and 3 did not result in additive therapeutic outcome, and caused increased total tissue volume and reduced BMD of the callus. This is the first report showing significant therapeutic effect of miR-29b-3p on femoral fracture healing through site-specific delivery with microbubble-ultrasound system. Further studies are warranted to investigate the underlying mechanisms and to refine the treatment protocol.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bone healing; Microbubble-ultrasound system; Mouse fracture; miR-29b-3p

Mesh:

Substances:

Year:  2016        PMID: 27113026     DOI: 10.1016/j.mce.2016.04.014

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  18 in total

1.  Involvement of microRNA-23b in TNF-α-reduced BMSC osteogenic differentiation via targeting runx2.

Authors:  Lin Deng; Guoli Hu; Lei Jin; Chenglong Wang; Hongwen Niu
Journal:  J Bone Miner Metab       Date:  2017-12-12       Impact factor: 2.626

Review 2.  Transcriptional Mechanisms of Secondary Fracture Healing.

Authors:  Joseph L Roberts; David N Paglia; Hicham Drissi
Journal:  Curr Osteoporos Rep       Date:  2018-04       Impact factor: 5.096

Review 3.  The Therapeutic Potential of MicroRNAs as Orthobiologics for Skeletal Fractures.

Authors:  Michael Hadjiargyrou; David E Komatsu
Journal:  J Bone Miner Res       Date:  2019-03-28       Impact factor: 6.741

4.  Age-associated changes in microRNAs affect the differentiation potential of human mesenchymal stem cells: Novel role of miR-29b-1-5p expression.

Authors:  Nada H Eisa; Periyasamy T Sudharsan; Sergio Mas Herrero; Samuel A Herberg; Brian F Volkman; Alexandra Aguilar-Pérez; Dmitry Kondrikov; Ahmed M Elmansi; Charles Reitman; Xingming Shi; Sadanand Fulzele; Meghan E McGee-Lawrence; Carlos M Isales; Mark W Hamrick; Maribeth H Johnson; Jie Chen; William D Hill
Journal:  Bone       Date:  2021-08-14       Impact factor: 4.398

Review 5.  MicroRNAs in orthopaedic research: Disease associations, potential therapeutic applications, and perspectives.

Authors:  Audrey McAlinden; Gun-Il Im
Journal:  J Orthop Res       Date:  2017-12-19       Impact factor: 3.494

6.  Silk Biomaterials-Mediated miRNA Functionalized Orthopedic Devices.

Authors:  Eric N James; Emily Van Doren; Chunmei Li; David L Kaplan
Journal:  Tissue Eng Part A       Date:  2018-08-22       Impact factor: 3.845

Review 7.  Development of controlled drug delivery systems for bone fracture-targeted therapeutic delivery: A review.

Authors:  Yuchen Wang; Maureen R Newman; Danielle S W Benoit
Journal:  Eur J Pharm Biopharm       Date:  2018-02-19       Impact factor: 5.571

Review 8.  The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies.

Authors:  Maria Rosa Iaquinta; Carmen Lanzillotti; Chiara Mazziotta; Ilaria Bononi; Francesca Frontini; Elisa Mazzoni; Lucia Oton-Gonzalez; John Charles Rotondo; Elena Torreggiani; Mauro Tognon; Fernanda Martini
Journal:  Theranostics       Date:  2021-04-30       Impact factor: 11.556

9.  Methyltransferase-like 3-mediated N6-methyladenosine modification of miR-7212-5p drives osteoblast differentiation and fracture healing.

Authors:  Bobin Mi; Yuan Xiong; Chenchen Yan; Lang Chen; Hang Xue; Adriana C Panayi; Liangcong Hu; Yiqiang Hu; Wu Zhou; Faqi Cao; Guohui Liu
Journal:  J Cell Mol Med       Date:  2020-04-19       Impact factor: 5.310

10.  Age-related increase of kynurenine enhances miR29b-1-5p to decrease both CXCL12 signaling and the epigenetic enzyme Hdac3 in bone marrow stromal cells.

Authors:  Ahmed M Elmansi; Khaled A Hussein; Sergio Mas Herrero; Sudharsan Periyasamy-Thandavan; Alexandra Aguilar-Pérez; Galina Kondrikova; Dmitry Kondrikov; Nada H Eisa; Jessica L Pierce; Helen Kaiser; Ke-Hong Ding; Aisha L Walker; Xue Jiang; Wendy B Bollag; Mohammed Elsalanty; Qing Zhong; Xing-Ming Shi; Yun Su; Maribeth Johnson; Monte Hunter; Charles Reitman; Brian F Volkman; Mark W Hamrick; Carlos M Isales; Sadanand Fulzele; Meghan E McGee-Lawrence; William D Hill
Journal:  Bone Rep       Date:  2020-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.